Case Studies in BRASH Syndrome: Bradycardia, Renal Failure, AV Blocker, Shock and Hyperkalemia

Author(s): Pritts Wanda

Contact Hours 1.00

CERP A 1.00

Expires Dec 31, 2025

Topics: Renal

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

BRASH syndrome (bradycardia, renal failure, AV nodal blockade, shock and hyperkalemia) is a newly recognized syndrome in which the synergistic effects of renal failure and AV nodal medication lead to severe bradycardia and hyperkalemia. The resulting shock intensifies the often refractory bradycardia and hyperkalemia. Predisposing factors, recognition and priorities for intervention are detailed in this intermediate level case-based presentation.

Objectives

  • Explain the pathophysiology of BRASH syndrome with emphasis on the synergistic elements.
  • Describe the assessment of the patient with BRASH syndrome and prioritize initial interventions.
  • Develop a plan of care for the patient experiencing BRASH syndrome with emphasis on interventions for refractory elements of syndrome.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.